Clinical Trial Update: VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 SAD/MAD safety and pharmacokinetics study of VNRX-5133 in healthy adults has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• VNRX-5133

Snippet

Sponsor: Venatorx Pharmaceuticals, Inc. | Conditions: Bacterial Infections | Phase 1 | Status: COMPLETED